Medicare program: Medicare Advantage and Prescription Drug Benefit programs: final marketing provisions. Final rule.
This final rule revises the Medicare Advantage (MA) program (Part C) and Medicare Prescription Drug Benefit Program (Part D). The regulation contains new regulatory provisions regarding marketing processes for both programs. The revisions to the Part C and Part D programs are based on lessons we have learned since 2006, the initial year of the prescription drug program and the revised MA program.
D014487:Centers for Medicare and Medicaid Services, U.S.; D011307:Drug Prescriptions / Q000191:economics; D006801:Humans; D007356:Insurance, Pharmaceutical Services / Q000191:economics / Q000331:legislation & jurisprudence*; D007880:Legislation, Drug / Q000191:economics; D008389:Marketing of Health Services / Q000331:legislation & jurisprudence*; D006278:Medicare / Q000191:economics / Q000331:legislation & jurisprudence; D020398:Medicare Part C / Q000191:economics / Q000331:legislation & jurisprudence*; D014481:United States